生物工程和生物手艺前沿 SCIE

期刊简介估计审稿时候： 12 Weeks

The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.

In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.

将医学上的新发明转化为临床惯例历来都不是一件轻易的事。在上个世纪下半叶，因为化学、生归天学和药理学的前进，咱们看到了大批药物和装备的开辟和利用，这些药物和装备旨在医治病症、阻断不用要的路子，并在沾抱病的环境下匹敌致使疾病的微生物。但是，明天，咱们正面临着病理和疾病医治体例的庞大变更。现实上，此刻和将来十年的挑衅是完整规复得病生物体的心理状况，并在构造和器官遭到严峻影响以致于医治不能规模于按捺病症或修复毁伤时完整再生构造和器官。这得益于根本细胞和份子生物学的严重成长，包含干细胞迷信、发展因子通报、基因分手和转染，生物工程和纳米手艺的前进，包含重生物资料的开辟、生物制作手艺和生物反应器的利用，和诊断东西和细胞、构造和器官成像的庞大改良。

在现当代界，增强多学科专家之间的交换，增进结合名目和迷信家、工程师、行业人士、羁系机构和大夫之间的紧密亲密协作，是胜利开辟和临床利用重生物疗法或立异装备（触及生物资料、细胞和/或生物活性份子的小我利用）的绝对请求。“生物工程和生物手艺前沿”但愿成为到场这一进程的一切人的一个服装论坛t.vhao.net，弥合根本迷信发明与其临床利用之间常常存在的差异。

《Frontiers In Bioengineering And Biotechnology》(生物工程和生物手艺前沿)编辑部通信体例为AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。